bioRxivPhysiologyPreprint
Engineering, Generation and Preliminary Characterization of a Humanized Porcine Sickle Cell Disease Animal Model
T. M. Franks, S. J. Haugabook, E. A. Ottinger, M. S. Vermillion, K. M. Pawlik, T. M. Townes, C. S. Rogers
Abstract
Mouse models of sickle cell disease (SCD) that faithfully switch from fetal to adult hemoglobin (Hb) have been important research tools that accelerated advancement towards treatments and cures for SCD. Red blood cells (RBCs) in these animals sickled in vivo, occluded small vessels in many organs and resulted in severe anemia like in human patients. SCD mouse models have been valuable in advancing clinical translation of some therapeutics and providing a better understanding of the pathophysiology of SCD. However, mouse models vary greatly from humans in their anatomy and physiology and therefore have limited application for certain translational efforts to transition from the bench to bedside. These differences create the need for a higher order animal model to continue the advancement of efforts in not only understanding relevant underlying pathophysiology, but also the translational aspects necessary for the development of better therapeutics to treat or cure SCD. Here we describe the development of a humanized porcine sickle cell model that like the SCD mice, expresses human [a]-, {beta}- and {gamma}-globin genes under the control of the respective endogenous porcine locus control regions (LCR). We also describe our initial characterization of the SCD pigs and plans to make this model available to the broader research community.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Therapeutic potential of oxygen through M101 transportation in reducing vaso-occlusion and hemolysis in a mouse model of sickle cell disease.
Franck Zal, Rachel Rignault‐Bricard, … Thiago Trovati Maciel·bioRxiv·Jun 18, 2025
- Cas9-AAV6 Gene Correction of Beta-Globin in Autologous HSCs Improves Sickle Cell Disease Erythropoiesis in Mice
Adam C. Wilkinson, Daniel P. Dever, … Matthew Hebden Porteus·Nature CommunicationsPeer-reviewed·Jan 29, 2021
- Novel engraftment and T cell differentiation of human hematopoietic cells in Art-/- IL2RG-/ SCID pigs
A. Boettcher, Y. Li, … C. Tuggle·bioRxiv·May 2, 2019
- Evaluation of persistence and fate of ex vivo edited-HSC modified with donor template and Its role in correcting Sickle Cell Disease
Sowmya Pattabhi, Samantha N. Lotti, … David J. Rawlings·bioRxiv·Jun 30, 2021
- Life-long hydroxyurea treatment decreases chronic sickle cell disease pain
Nya Gayluak, Sourav Roy, … Katelyn E. Sadler·bioRxiv·Aug 30, 2025
- Senolytics Restore Hematopoietic Stem Cells Function in Sickle Cell Disease
Aditya Barve, Adam B. Cornwell, … Shannon McKinney‐Freeman·bioRxiv·Feb 8, 2025